Biotechnology

27 March 2025   Combining USPTO work with a background in molecular biology, immunology, and plant biochemistry, the new counsel brings patent practitioner and examiner skills to the firm.

Latest Features

Americas
Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.
Americas
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone.
Asia
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert.
Biotechnology
AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap.
Biotechnology
As artificial intelligence creates a complex legal landscape for healthcare and medtech, Janine Swarbrick of HGF explores two case studies that shed light on how to claim an AI invention.
All features


More News

6 March 2025   Return-to-office orders, redundancies, hiring freezes—do changes sweeping through the US agency ‘risk breaking the system’? Marisa Woutersen finds patent practitioners fearful of the future.
6 March 2025   New York biotech scores win as Fed Circ upholds preliminary injunction against Celltrion's biosimilar launch | Ruling follows intense scrutiny during Federal Circuit oral arguments | Decision follows similar rulings against Samsung Bioepis and Formycon.
4 March 2025   Based in Silicon Valley and San Francisco, the duo bring experience in patent litigation across life sciences, biotechnology, and high technology, including a recent victory overturning a $96 million jury verdict in an organ transplant testing case.
4 March 2025   UK biotech firm accuses luxury skincare brand La Prairie of misappropriating proprietary research on caviar-derived ingredients | Lawsuit claims La Prairie lacked expertise to develop the tech before accessing confidential trade secrets.
27 February 2025   Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner brings experience in biotechnology, life sciences, technology, artificial intelligence and sustainable energy.
11 February 2025   Key ruling in favour of Kansas-based biotech on genetically engineered proteins from China | Court supports ITC position | Small market segments can be substantial enough for domestic industry requirement.
11 February 2025   Five partners from Knobbe Martens join the firm | New arrivals bolster Morgan Lewis’s capabilities in patent and trademark litigation.
More news